Correlation of HTR2A-rs7997012 with the risk of treatment-resistant depression and the efficacy of modified electroconvulsive therapy
10.3760/cma.j.cn112150-20250224-00133
- VernacularTitle:HTR2A-rs7997012基因与难治性抑郁症风险和改良电休克疗效的相关性研究
- Author:
Ting ZHANG
1
;
Hongxin LU
;
Qingmin RAO
;
Yongyin HE
;
Wenyan GE
;
Junlin LIU
;
Haiying LIU
;
Yulong LIN
Author Information
1. 广州医科大学附属脑科医院检验科，广州 510370
- Publication Type:Journal Article
- Keywords:
Non-treatment resistant depression;
Treatment resistant depression;
Polymorphism
- From:
Chinese Journal of Preventive Medicine
2025;59(11):1897-1905
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This study aimed to investigate the association between genetic factors and the risk of developing treatment-resistant depression (TRD), as well as the efficacy of modified electroconvulsive therapy (MECT), with a specific focus on identifying gene polymorphisms that can differentiate TRD from non-TRD.Methods:This case-control study included inpatients with depression in Adult Psychiatry Department, Affective Disorders Department and Geriatrics Department of Guangzhou Medical University Affiliated Brain Hospital from January 2023 to June 2024, as well as healthy individuals undergoing physical examinations in the outpatient department. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was utilized to genotype 16 loci across 10 candidate genes in 107 non-TRD patients, 101 TRD patients and 281 healthy controls. Hardy-Weinberg equilibrium testing, genotype frequency distribution analysis, and genetic association studies were conducted using PLINK software. Univariate binary logistic regression under a dominant model was performed using R software to analyze gene loci associated with non-TRD and TRD.Results:All 16 gene loci in the control group, the TRD group, and the non-TRD group were found to be in Hardy-Weinberg equilibrium ( P>0.05). No significant differences were observed in the genotype distribution of these gene loci across the groups ( P>0.05). Univariate binary logistic regression analysis revealed that individuals with depression carrying the HTR2A-rs7997012 G allele had a significantly lower risk of developing TRD ( OR=0.26, P=0.047). Among the patients receiving MECT, the proportion of G allele carriers who showed improvement at 2, 4, and 6 weeks of treatment was significantly higher compared to those who did not show improvement (96.61% vs. 80.95%, 96.55% vs. 50.00%, 96.59% vs. 46.15%, respectively), with χ2 values of 6.743, 29.295, and 32.300, respectively, and all P values <0.05. Conclusion:The HTR2A-rs7997012 polymorphism may represent a genetic distinction between TRD and non-TRD. Depressed patients with the rs7997012 G allele have a reduced likelihood of developing TRD, moreover, MECT demonstrates superior efficacy in this patient population.
